Enochian Biosciences, Inc Earning Date (ENOB)

USA |NASDAQ |USD

ENOB Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Sep 30, 2022 (est) Jun 30, 2022 - $-0.12 $-0.20
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Sep 30, 2022 (est) Jun 30, 2022 - $0.00 $0.00

Enochian Biosciences, Inc's next estimated earnings date (based on same quarter last year's date) is Sep 30, 2022 for the fiscal quarter ending Jun 30, 2022.

ENOB Earnings Date & History Chart

ENOB Earnings Date & Revenue History

ENOB Earnings History

|
Show More
Show More

ENOB Revenue History

|
Show More
Show More

Enochian Biosciences, Inc Next Earnings Date & Report

ENOB Mar 2022 (FQ) Earnings Date & Report Preview

ENOB's next estimated earnings date (based on same quarter last year's report date) is Sep 30, 2022 for the fiscal quarter ending Jun 30, 2022.

Enochian Biosciences, Inc Previous Earnings Dates & Reports

ENOB Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Enochian Biosciences, Inc's previous earnings date was Mar 31, 2022 for its fiscal quarter ended Mar 31, 2022.

ENOB's earnings per share (EPS) was $-0.12.

The EPS was higher than the previous fiscal quarter (Dec 2021) by -6.36%, and higher than the same period a year before (Mar 2021) by -64.57%.

Revenues were $0.00.

The company reported a net income of $-6.20M.

Free cash flow for the quarter was $-2.78M , compared to $-9.90M last quarter and $-2.33M a year before.

ENOB ended the quarter with $7.32M in total debt, an increase of 13.97% compared to the previous quarter, and an increase of 0.14% compared to the same quarter a year before.

ENOB Previous Earnings Date & Report Recap: Jun 2021 (FY)

Enochian Biosciences, Inc's previous annual earnings date was Sep 30, 2021 for its fiscal year ended Jun 30, 2021.

ENOB's earnings per share (EPS) was $-0.68.

Revenues were $0.00.

The company reported a net income of $-26.72M.

Enochian Biosciences, Inc reported a free cash flow of $-20.66M for its fiscal year, compared to $-10.64M a year ago.

The company ended the fiscal year with $7.31M in total debt, an increase of 20.80% compared to the previous year.